Erck becomes CEO in Novavax turnover; Aoxing gets Macfarlan Smith process tech;

> At VLP vaccine developer Novavax, Stanley Erck has been named president and CEO, replacing Rahul Singhvi; James Young becomes chairman. Novavax release

> In the joint venture between Aoxing Pharma and Macfarlan Smith, the latter has transferred its process technology to the former for use in producing API naloxone hydrochloride. Announcement

> Axios Mobile Assets Corp. announced it has achieved FDA compliance for its proprietary trackable pallet and software technology. Axios release

> Logistics service provider Panalpina has announced the accreditation of 20 cool chain locations--10 in Asia--boosting its Qualified Envirotainer Provider status to 43 locations in 27 countries. Item

> Ireland's Corden Pharmachem and two of its executives return to court in the case of a 2008 explosion that killed one worker and seriously injured another. Story

> Bedford Laboratories is now manufacturing topotecan hydrochloride for injection, 4 mg (base)/vial, a bioequivalent to GSK's Hycamtin. Bedford release

> Adeona Pharmaceuticals has agreed to offer commercial-scale manufacturing capabilities for reaZin to Florida-based pharmaceutical preparation manufacturing company TG United. Story

> Indian drugmaker Strides Arcolab has received FDA approval for its new sterile injectables facility in Bangalore, used in the production of lyophilized liquid and dry powder injectables. Item